ライブ
Lonza NewsStipple Bio taps Lonza platform to advance ADC pipeline - The Pharma LetterCellSingle-cell mapping of regulatory DNA-protein interactionsCellPlasma signals of lung tumor promotion for molecular cancer preventionCellDeep learning of functional perturbations from condensate morphologyFierceBiotechAt first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from expertsLonza NewsStipple Bio taps Lonza platform to advance ADC pipeline - The Pharma LetterLabiotechEpisode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech mediaLonza NewsLonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma PostEli LillyGilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSNThermo FisherThe Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why - Yahoo FinanceeLifeThe NTR/prodrug revolution: Tools for controlling cell loss and regenerationBio-Gene Technology LtdBio-Gene lifts placement size with additional shares and options - TipRanks
Promega Blog 2026年3月12日

Light Has a Favorite Color, But It’s Complicated

Light Has a Favorite Color, But It’s Complicated

原文
本文は利用できません。元の情報源をご確認ください。